ArticleJournal of cancer research and clinical oncology2024
Evaluation of changes in the clinical benefits of oncology drugs over time following reimbursement using the ASCO-VF and the ESMO-MCBS.
Na Ri Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.